3.0.0 4404 2022-11-01T13:49:56Z 2022-11-01T13:49:56Z House HR 2019-09-19 116 [Congressional Record Volume 165, Number 151 (Thursday, September 19, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. RUSH:H.R. 4404.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H7836]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-09-20T16:19:28Z Referred to 2019-09-19T14:02:20Z 2019-09-20 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-09-19 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-09-19 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-09-19 Introduced in House IntroReferral 1000 9 Library of Congress R000515 Rep. Rush, Bobby L. [D-IL-1] BOBBY RUSH D IL L. 1 N J000032 Rep. Jackson Lee, Sheila [D-TX-18] SHEILA JACKSON LEE D TX 18 2019-09-25 False D000624 Rep. Dingell, Debbie [D-MI-12] Debbie Dingell D MI 12 2019-10-04 False C001072 Rep. Carson, Andre [D-IN-7] Andre Carson D IN 7 2019-11-12 False W000826 Rep. Wild, Susan [D-PA-7] Susan Wild D PA 7 2019-12-04 False T000193 Rep. Thompson, Bennie G. [D-MS-2] BENNIE THOMPSON D MS 2 2019-12-09 False H000324 Rep. Hastings, Alcee L. [D-FL-20] ALCEE HASTINGS D FL L. 20 2020-01-21 False S001204 Del. San Nicolas, Michael F. Q. [D-GU-At Large] Michael San Nicolas D GU F. Q. 0 2020-07-21 False Health Administrative law and regulatory procedures Consumer affairs Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Mental health Health 00 2019-09-19 Introduced in House 2021-09-13T19:25:14Z Depression Side Effect Labeling Awareness Act of 2019

This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.

]]> Depression Side Effect Labeling Awareness Act of 2019 Display Title Depression Side Effect Labeling Awareness Act of 2019 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to require that the label of drugs with an increased risk of suicide or depression present such increased risk prominently, and for other purposes. Introduced in House IH Short Title(s) as Introduced Depression Side Effect Labeling Awareness Act of 2019 Introduced in House IH Introduced in House 2019-09-19T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr4404ih/xml/BILLS-116hr4404ih.xml 2019-09-20 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.